International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 2/28/2025 | 8/31/2024 | 2/29/2024 | |
|---|---|---|---|---|
| Revenue | £5,991 | £12,695 | £10,469 | £32,414 |
| % Growth | -52.8% | 21.3% | -67.7% | – |
| Cost of Goods Sold | £1,533 | £2,770 | -£457 | £5,316 |
| Gross Profit | £1,688 | £12,695 | £10,926 | £27,098 |
| % Margin | 28.2% | 100% | 104.4% | 83.6% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £3,269 | £49 | £3,379 |
| SG&A Expenses | £0 | £3,269 | £49 | £3,379 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £3,269 | £49 | £3,379 |
| Operating Income | -£9,447 | £9,426 | £10,518 | £29,035 |
| % Margin | -157.7% | 74.2% | 100.5% | 89.6% |
| Other Income/Exp. Net | £1,253 | -£2,374 | £89 | -£631 |
| Pre-Tax Income | -£8,194 | £7,052 | £10,607 | £28,404 |
| Tax Expense | £10 | £18 | £64 | £71 |
| Net Income | -£8,204 | £7,034 | £10,543 | £28,333 |
| % Margin | -136.9% | 55.4% | 100.7% | 87.4% |
| EPS | -0.23 | 0.19 | 0.29 | 0.73 |
| % Growth | -221.1% | -34.5% | -60.3% | – |
| EPS Diluted | -0.23 | 0.19 | 0.29 | 0.73 |
| Weighted Avg Shares Out | 35,541 | 36,244 | 36,835 | 38,880 |
| Weighted Avg Shares Out Dil | 35,541 | 36,243 | 36,835 | 38,880 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | -£1,042 | £1,260 |
| Interest Expense | £0 | £917 | £0 | £0 |
| Depreciation & Amortization | £0 | -£9,426 | £0 | -£29,035 |
| EBITDA | -£9,447 | £0 | £10,518 | -£631 |
| % Margin | -157.7% | 0% | 100.5% | -1.9% |